| 摘要 |
<p>The invention relates to novel benzimidazoles of general formula (I), wherein Ra to Rc have the meanings given in claim no.1, to their tautomers, their stereoisomers, their mixtures, their prodrugs, their derivatives containing a group which has been negatively charged under physiological conditions instead of a carboxy group; and their salts, especially their physiologically compatible salts with inorganic or organic acids or bases; with valuable properties. The compounds of general formula (I) wherein Rc does not represent an amidino group, are valuable intermediate products for producing amidino compounds of general formula (I) which have valuable pharmacological properties, especially an antithrombotic effect.</p> |
